Beam Therapeutics, Inc. (BEAM)
31.47
-0.87
(-2.69%)
USD |
NASDAQ |
May 07, 16:00
31.72
+0.25
(+0.79%)
Pre-Market: 08:43
Beam Therapeutics Research and Development Expense (Annual) : 409.62M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 379.09M |
| Twist Bioscience Corp. | 80.28M |
| Stryker Corp. | 1.567B |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Tandem Diabetes Care, Inc. | 174.84M |